KL
MXCT icon

KWMG LLC’s MaxCyte MXCT Stock Holding History

KWMG LLC’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.8K Hold
25,833
– – ﹤0.01% 153
2026
Q1 		$18.1K Hold
25,833
– – ﹤0.01% 147
2025
Q4 		$40K Hold
25,833
– – ﹤0.01% 149
2025
Q3 		$40.8K Buy
25,833
+11,135
+76% +$19.4K ﹤0.01% 150
2025
Q2 		$32K Hold
14,698
– – ﹤0.01% 146
2025
Q1 		$40.1K Buy
+14,698
New +$58K ﹤0.01% 143

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

KWMG LLC's MXCT Position: Q2 2026 in Review

KWMG LLC held its MaxCyte (MXCT) position steady in Q2 2026 at 25,833 shares worth $31.8K. The position accounts for ﹤0.01% of the portfolio, ranked #153.

KWMG LLC first reported a position in MXCT in Q1 2025 and has held it in 6 quarters since. The position peaked at $40.8K in Q3 2025. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • KWMG LLC held 25,833 shares of MaxCyte worth $31.8K as of Q2 2026.
  • KWMG LLC left its MaxCyte share count unchanged in Q2 2026.
  • MaxCyte made up ﹤0.01% of KWMG LLC's portfolio in Q2 2026, its #153 holding.
  • KWMG LLC first reported a position in MaxCyte in Q1 2025 and has held it in 6 quarters since.
  • KWMG LLC's MaxCyte position peaked at $40.8K in Q3 2025.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on KWMG LLC's 13F filing for Q2 2026, filed 8 Jul 2026.